(Q37656198)

21 August 2017

title

The cost and incidence of prescribing errors among privately insured HIV patients (English)

1 reference

21 August 2017

0 references

Fred J Hellinger

1

1 reference

21 August 2017

William E Encinosa

series ordinal

2

1 reference

21 August 2017

publication date

1 January 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

28

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

23-34

1 reference

Antiretroviral medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital.

21 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11313810-000000000-00000

Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11313810-000000000-00000

Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11313810-000000000-00000

Antiretroviral prescribing errors in hospitalized patients

21 January 2018

1 reference

12 December 2020

HIV infection in hospitalized patients and Medicaid enrollees: the accuracy of medical record coding

1 reference

12 December 2020

The effect of hospital experience on mortality among patients hospitalized with acquired immunodeficiency syndrome in California

1 reference

12 December 2020

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS.

1 reference

12 December 2020

The 'Medicaidization' of AIDS. Trends in the financing of HIV-related medical care

1 reference

12 December 2020

Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.

1 reference

12 December 2020

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

12 December 2020

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy

1 reference

12 December 2020

The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Enfuvirtide: first fusion inhibitor for treatment of HIV infection

1 reference

12 December 2020

Profile of Medicare beneficiaries with AIDS: application of an AIDS casefinding algorithm.

1 reference

12 December 2020

Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes

1 reference

12 December 2020

Increased use of lipid-lowering therapy in patients receiving human immunodeficiency virus protease inhibitors

1 reference

12 December 2020

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

Inappropriate drug combinations among privately insured patients with HIV disease

1 reference

12 December 2020

The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs Hospitals 1987-1991.

1 reference

12 December 2020

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

12 December 2020

Distribution of health care expenditures for HIV-infected patients

1 reference

12 December 2020

Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults

1 reference

12 December 2020

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

1 reference

12 December 2020

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group

1 reference

12 December 2020

Assessing the risk of drug-induced neurologic disorders: statins and neuropathy

1 reference

12 December 2020

Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states

1 reference

12 December 2020

The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP.

1 reference

12 December 2020

The lifetime cost of treating a person with HIV.

1 reference

12 December 2020

Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons

1 reference

12 December 2020

What drove private health insurance spending on mental health and substance abuse care, 1992-1999?

1 reference

12 December 2020

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium

1 reference

12 December 2020

Risk for myopathy with statin therapy in high-risk patients.

1 reference

12 December 2020

Medication-prescribing errors in a teaching hospital. A 9-year experience

1 reference

12 December 2020

Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.

1 reference

12 December 2020

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

1 reference

12 December 2020

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis

1 reference

12 December 2020

10.2165/11313810-000000000-00000

Identifiers

DOI

1 reference

21 August 2017

1 reference